awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
CLC.22327
CLC.22327
http://dx.doi.org/10.1002/CLC.22327
Efficacy and safety of alirocumab as add-on therapy in high-cardiovascular-risk patients with hypercholesterolemia not adequately controlled with atorvastatin (20 or 40 mg) or rosuvastatin (10 or 20 mg): design and rationale of the ODYSSEY OPTIONS S
P356
Q34805650-0A9C0147-0F9A-4FC7-A92A-38247F33AB2E
P356
CLC.22327
http://dx.doi.org/10.1002/CLC.22327